Table 1.

List of speakers and titles of presentation^a

1. Andersson, Monique, Stellenbosch University & University Hospitals NHS Trust, University of Oxford ‘PMTCT for HBV’
2. Andrieux-Meyer, Isabelle, MSF Opening overview and community perspective’
3. Boyd, Anders, INSERM ‘HBV resistance and escape mutants’
4. Easterbrook, Philippa, WHO ‘WHO Diagnostic Guidelines’
5. Hardie, Diana, University of Cape Town ‘Screening for viral hepatitis: Diagnostics (HBV and HCV)’
6. Hellard, Margaret, Burnet Institute ‘Current trends worldwide: Implications for elimination’
7. Kennedy, Patrick, Barts and The London School of Medicine ‘Curing HBV: How close are we?’ ‘HCC screening and management’
8. Khwairakpam, Giten, TREAT Asia Panel discussion - ‘Accessing antivirals: Overcoming remaining challenges’
9. Klein, Marina, McGill University; CIHR Canadian HIV Trials Network (CTN) ‘Is a pan-genotypic therapy ready for prime time?’ (presented by Rockstroh, Jürgen) ‘Closing remarks’ (presented by Rockstroh, Jürgen)
10. Luhmann, Niklas, Médecins du Monde ‘HCV in PWID in Africa: A hidden epidemic’
11. Medeiros, Nelson, OUT Wellbeing Panel discussion - ‘Accessing antivirals: Overcoming remaining challenges’
12. Meyers, Tammy, Chinese University of Hong Kong ‘Children and adolescents’
13. Perry, Greg, Medicines Patent Pool ‘Medicines Patent Pool’
14. Rajkumar, Nalinikanta, Community Network for Empowerment (CoNE) Panel discussion - ‘Accessing antivirals: Overcoming remaining challenges’
15. Rockstroh, Jürgen, University of Bonn ‘Role of resistance and resistance testing for managing HCV’
16. Scheibe, Andrew, University of Cape Town & TB/HIV Care Association Panel discussion - ‘Accessing antivirals: Overcoming remaining challenges’
17. Solomon, Sunil, Johns Hopkins University ‘Financing and scale up of HCV treatments: Entry of generics’
18. Sonderup, Mark, University of Cape Town ‘HBV-HIV co-infection: Epidemiology, vaccine and treatment coverage’ Panel discussion - ‘Accessing antivirals: Overcoming remaining challenges’
19. Spearman, Wendy, University of Cape Town ‘Welcome and introduction’ ‘Screening for viral hepatitis: Liver disease’

^aSlide sets presented at the meeting are publicly available on the AIDS 2016 Online Conference Programme at http://programme.aids2016.org/Programme/Session/1157 and on the IAS website at http://www.iasociety.org/HIV-programmes/Co-Infections/3rd-International-HIV-Viral-Hepatitis-Co-Infection-Meeting/Hepatitis-Meeting-Presentations